GBUZ Clinical dermatology and venereological dispensary

Krasnodar 350000

0 studies enrolling now · 2 studies all time

What they study most

Plaque Psoriasis, Psoriasis

Studies at this site

• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis — Completed